Cargando…

Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma

p53 alterations are considered to be predictive of poor prognosis in hepatocellular carcinoma (HCC) and may induce a humoral response. Anti-p53 serum antibodies were assessed by enzyme-linked immunosorbent assay (ELISA) using purified recombinant human p53 on 130 European HCC patients before treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saffroy, R, Lelong, J-C, Azoulay, D, Salvucci, M, Reynes, M, Bismuth, H, Debuire, B, Lemoine, A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362420/ https://www.ncbi.nlm.nih.gov/pubmed/10027337 http://dx.doi.org/10.1038/sj.bjc.6690095

Ejemplares similares

Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies
por: Moch, C, et al.
Publicado: (2001)

Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy
por: Blanchard, Pierre, et al.
Publicado: (2012)

p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer
por: Schneider, J, et al.
Publicado: (1999)

The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas
por: Andersson, S, et al.
Publicado: (2001)

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (2001)

Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status
por: Brodowicz, T, et al.
Publicado: (2001)

Serum p53 antibodies: predictors of survival in small-cell lung cancer?
por: Murray, P V, et al.
Publicado: (2000)

Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade
por: Wu, C-W, et al.
Publicado: (1999)

Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (1999)

Reduced p21(WAF1/CIP1)protein expression is predominantly related to altered p53 in hepatocellular carcinomas
por: Shi, Y-Z, et al.
Publicado: (2000)

The Significance of Strong Ion Gap for Predicting Return of Spontaneous Circulation in Patients with Cardiopulmonary Arrest
por: Kaneko, Minoru, et al.
Publicado: (2017)

Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations
por: Rashid, A, et al.
Publicado: (1999)

Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes
por: Ogg, G S, et al.
Publicado: (2000)

Human anti-CD30 recombinant antibodies by guided phage antibody selection using cell panning
por: Klimka, A, et al.
Publicado: (2000)

Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study
por: Lenner, P, et al.
Publicado: (1999)

Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice
por: Flavell, D J, et al.
Publicado: (2000)

Mathematical and experimental analysis of localization of anti-tumour antibody–enzyme conjugates
por: Jackson, T L, et al.
Publicado: (1999)

Flow cytometry analysis of anti-polyethylene glycol antibodies in human plasma()
por: Fang, Jia-Long, et al.
Publicado: (2020)

Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer
por: Simms, M S, et al.
Publicado: (2000)

Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients
por: Park, Borae Geum, et al.
Publicado: (2019)

Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies
por: Dade, Maëlle, et al.
Publicado: (2021)

Different types of FC γ -receptors are involved in anti-Lewis Y antibody induced effector functions in vitro
por: Dettke, M, et al.
Publicado: (2000)

Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2
por: Kunisue, H, et al.
Publicado: (2000)

Hepatocellular carcinoma
por: Giovannini, M, et al.
Publicado: (2001)

Undetectable RAS-Mutant Clones in Plasma: Possible Implication for Anti-EGFR Therapy and Prognosis in Patients With RAS-Mutant Metastatic Colorectal Cancer
por: Bouchahda, Mohamed, et al.
Publicado: (2020)

Serum anti-P53 antibodies and alpha-fetoprotein in patients with non-B non-C hepatocellular carcinoma
por: El Azm, Abdel Raouf Abou, et al.
Publicado: (2013)

Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma: Evidence from a meta-analysis
por: Chang, Yue, et al.
Publicado: (2020)

Comparative toxicity, phytochemistry, and use of 53 Philippine medicinal plants
por: Clemen-Pascual, Lydia M., et al.
Publicado: (2021)

The European mesothelioma epidemic
por: Peto, J, et al.
Publicado: (1999)

Glycerol restores p53-dependent radiosensitivity of human head and neck cancer cells bearing mutant p53
por: Ohnishi, K, et al.
Publicado: (2000)

Mutation analysis of P73 and TP53 in Merkel cell carcinoma
por: Gele, M Van, et al.
Publicado: (2000)

Telomerase activity and p53-dependent apoptosis in ovarian cancer cells
por: Akeshima, R, et al.
Publicado: (2001)

p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer
por: Ferrandina, G, et al.
Publicado: (1999)

p53 mutations in urinary bladder cancer
por: Berggren, P, et al.
Publicado: (2001)

Animal models for anti‐neutrophil cytoplasmic antibody‐associated vasculitis: Are current models good enough?
por: Huang, Fei, et al.
Publicado: (2023)

Loss of heterozygosity is related to p53 mutations and smoking in lung cancer
por: Zienolddiny, S, et al.
Publicado: (2001)

In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases
por: Emanuels, A G, et al.
Publicado: (1999)

Mutational status of K- ras and TP53 genes in primary sarcomas of the heart
por: Garcia, J M, et al.
Publicado: (2000)

FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines
por: EI-Hariry, I, et al.
Publicado: (2001)

Immunohistochemical Mapping of Bcl9 Using Two Antibodies that Recognize Different Epitopes Is Useful to Characterize Juvenile Development of Hepatocellular Carcinoma in Myanmar
por: Soe, Myat Thu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a9ugfkj09qnrhv2elsvgroqcbe